JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB312397

Alexa Fluor® 568 Anti-Claudin 7 / CLDN-7 antibody [EPR18073]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal Claudin 7 antibody - conjugated to Alexa Fluor® 568.

View Alternative Names

CEPTRL2, CPETRL2, CLDN7, Claudin-7, CLDN-7

  • 578 PE

    PE Anti-Claudin 7/CLDN-7 antibody [EPR18073]

  • 660 APC

    APC Anti-Claudin 7/CLDN-7 antibody [EPR18073]

  • HRP

    HRP Anti-Claudin 7/CLDN-7 antibody [EPR18073]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Claudin 7 / CLDN-7 antibody [EPR18073]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Claudin 7 / CLDN-7 antibody [EPR18073]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Claudin 7 / CLDN-7 antibody [EPR18073]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Claudin 7 / CLDN-7 antibody [EPR18073]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-Claudin 7/CLDN-7 antibody [EPR18073]

  • Unconjugated

    Anti-Claudin 7/CLDN-7 antibody [EPR18073]

  • Carrier free

    Anti-Claudin 7/CLDN-7 antibody [EPR18073] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR18073

Isotype

IgG

Conjugation

Alexa Fluor® 568

Excitation/Emission

Ex: 578nm, Em: 603nm

Carrier free

No

Applications

Antibody Labelling, Target Binding Affinity

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Claudin 7 often referred to as CLDN-7 is a transmembrane protein with a molecular mass of approximately 22 kDa. It is part of the claudin family which includes other members like claudin-1 and claudin-3. CLDN-7 is prominently found in epithelial cells and plays an important role in forming tight junctions between cells. These tight junctions are integral in maintaining cell polarity and controlling the paracellular transport of ions and molecules.
Biological function summary

Claudin 7 contributes to the integrity and function of tight junctions by directly interacting with other claudins and zonula occludens-1 (ZO-1) thereby becoming part of a larger complex. This structure regulates the movement of substances between epithelial cells protecting tissues from pathogens and maintaining homeostasis. Claudin 7 is essential for proper barrier function in tissues like the respiratory tract and renal structures.

Pathways

The function of claudin 7 integrates within the epithelial barrier signaling pathway and the Wnt signaling pathway. Through these pathways CLDN-7 interacts with proteins like β-catenin. In the epithelial barrier pathway CLDN-7 helps maintain cellular adhesion and barrier function while in the Wnt pathway it might influence cell proliferation and differentiation indirectly through associated proteins.

Claudin 7 has a significant connection with certain cancers such as gastric and colorectal cancer. Alterations in CLDN-7 expression can disrupt cell adhesion leading to increased invasiveness of cancer cells. It is often observed that in these cancers changes in CLDN-7 expression correlate with E-cadherin another key protein in maintaining tissue architecture and integrity. Additionally variations in CLDN-7 are linked to renal disorders where disrupted tight junctions can affect kidney function.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a major role in tight junction-specific obliteration of the intercellular space.
See full target information CLDN7

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com